Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis

E. Balleari, R.A. Filiberti, C. Salvetti, B. Allione, E. Angelucci, M. Bruzzone, T. Calzamiglia, M. Cavaliere, M. Cavalleri, D. Cilloni, M. Clavio, E. Crisà, A. Da Col, P. Danise, F. Pilo, D. Ferrero, C. Finelli, D. Gioia, R.M. Lemoli, E. MasieraE. Messa, M. Miglino, P. Musto, E. Natalie Oliva, A. Poloni, F. Salvi, A. Sanna, M. Scudeletti, R. Tassara, V. Santini

Research output: Contribution to journalArticle

Cite this

Balleari, E., Filiberti, R. A., Salvetti, C., Allione, B., Angelucci, E., Bruzzone, M., Calzamiglia, T., Cavaliere, M., Cavalleri, M., Cilloni, D., Clavio, M., Crisà, E., Da Col, A., Danise, P., Pilo, F., Ferrero, D., Finelli, C., Gioia, D., Lemoli, R. M., ... Santini, V. (2019). Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis. Cancer Medicine. https://doi.org/10.1002/cam4.2638